India’s drug regulator flags 90 unapproved FDCs, directs states to take actionIndia's drug regulator has initiated a nationwide crackdown on unapproved fixed-dose combination drugs. At least 90 such medicines have bee...
23 Mar, 2026, 12.08 AM IST
Are your eye drops safe? CDSCO flags illegal products, doctors issue strong warning on irritation, conjunctivitisAuthorities have launched a major crackdown on unapproved dry eye relief drops being sold without mandatory CDSCO approval. States and Unio...
20 Mar, 2026, 03.37 PM IST
Delhi HC stops drug body from taking action against IndiaMartThe Delhi High Court has temporarily blocked the CDSCO from pursuing criminal action against IndiaMart for allegedly listing unapproved med...
10 Sep, 2025, 11.23 PM IST
Stricter shelf life rule a bitter pill to swallow for pharma companiesA new regulation by the CDSCO mandates that exported drugs must have at least 60% shelf life remaining, causing significant losses to the I...
26 Aug, 2025, 03.53 PM IST
Lancet report on unapproved antibiotic use in India is 'misleading, inappropriate': Govt officialProf. Y K Gupta, a senior pharmacologist and vice chairman of the Standing National Committee on Medicines (SNCM) which prepared the Nation...
14 Sep, 2022, 05.30 PM IST
Over 47 per cent antibiotic formulations used in India in 2019 unapproved: Lancet studyThe data were gathered from a panel of 9,000 stockists who store products from approximately 5,000 pharmaceutical companies.
07 Sep, 2022, 04.17 PM IST
Centre must take action against Ramdev for making unscientific statements against allopathy: IMARamdev should be prosecuted under the Epidemic Diseases Act as "untutored" statements are "a threat to the literate society of the country ...
23 May, 2021, 07.42 AM IST
SC seeks Centre's reply on plea alleging no approval for Remdesivir, Favipiravir to treat COVID-19A bench led by CJI S.A. Bobde issued notices to the central government on a petition filed by lawyer Manoharlal Sharma claiming that these ...
29 Oct, 2020, 10.02 PM IST
Awaiting critical Remdesivir safety data from companies: DCGIApart from BDR, all have entered into voluntary licensing agreements with Gilead Science, US-based patent holder of this drug. Gilead said ...
16 Jun, 2020, 07.37 AM IST
Novartis, U.S. regulators agree to malaria drug hydroxychloroquine trial against COVID-19Novartis has reached an agreement with U.S. regulators to hold a randomized trial of generic malaria drug hydroxychloroquine against COVID-...
20 Apr, 2020, 12.26 PM IST
Illegal cancer drugs from Bangladesh flood local marketIllegal import of drugs from Bangladesh and other neighbouring countries have further added to the woes of pharmaceutical companies. Expert...
18 Nov, 2019, 10.58 AM IST
Madras High Court bans online sales of medicinesThe court set January 31, 2019 as the deadline for the central government to notify the rules.
17 Dec, 2018, 09.20 PM IST
‘Banned ingredients in diet pills putting Indians at risk’Several dietary supplements, most of which are widely available in India, have been found adulterated with unapproved and even banned pharm...
27 Oct, 2018, 12.07 PM IST
64% of antibiotics sold in India unapproved, finds UK studyThe report said millions of antibiotic pills in the Indian market have not been regulated in India, the UK or US, worsening the problem of ...
05 Feb, 2018, 09.15 AM IST
Strides Arcolab working with USFDA on import alert on unit's productsThe company further wishes to clarify that it has no role in the distribution of any of these products in the US territory, Strides said.
01 Oct, 2014, 05.01 PM IST
- US Department of Justice to withdraw motion against Ranbaxy
Department Of Justice to withdraw motion to subpoena if company submits all audit documents in frauds case.
31 Jul, 2008, 04.40 AM IST
- Ranbaxy refutes DoJ's adulteration charges
Ranbaxy has refuted the charges levelled against it by US Department of Justice of not sharing audit information sought by US authorities. ...
15 Jul, 2008, 01.01 AM IST